Kathleen A Gallo (Kathleen Gallo)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Topics

Replacement Therapy

Gene Expression

Basal Cell Carcinoma

Top Venues

International journal of cancer

Molecules and cells

G3 (Bethesda, Md.)

Harvard University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Harvard University

United States

PHD :: Chemistry

Publications

Bardees M Foda, Sean A Misek, Kathleen A Gallo, Richard R Neubig
Inhibition of the Rho/MRTF pathway improves the response of BRAF-resistant melanoma to PD1/PDL1 blockade. International journal of cancer (2024)
Bardees M Foda, Sean A Misek, Kathleen A Gallo, Richard R Neubig
Inhibition of the Rho/MRTF pathway improves the response of BRAF-resistant melanoma to PD1/PDL1 blockade. International journal of cancer 155 (7) (2024)
Bardees M Foda, Sean A Misek, Kathleen A Gallo, Richard R Neubig
Inhibition of the Rho/MRTF pathway improves the response of BRAF-resistant melanoma to PD1/PDL1 blockade. International journal of cancer (2024)
Christopher J Occhiuto, Jessica A Moerland, Ana S Leal, Kathleen A Gallo, Karen T Liby
The Multi-Faceted Consequences of NRF2 Activation throughout Carcinogenesis. Molecules and cells 46 (3) (2023)
Christopher J Occhiuto, Jessica A Moerland, Ana S Leal, Kathleen A Gallo, Karen T Liby
The Multi-Faceted Consequences of NRF2 Activation throughout Carcinogenesis. Molecules and cells 46 (3) (2023)
Yeni L Bernal Rubio, Agustin González-Reymúndez, Kuan-Han H Wu, Corinne E Griguer, Juan P Steibel, Gustavo de Los Campos, Andrea I Doseff, Kathleen A Gallo, Ana I Vazquez
Whole-Genome Multi-omic Study of Survival in Patients with Glioblastoma Multiforme. G3 (Bethesda, Md.) 8 (11) (2018)